Argaam EN
US President Donald Trump announced a 100% duty on branded or patented drugs effective Oct. 1, unless manufacturers build production facilities in the US.
The measure targets medicines protected by trademarks, patents, or other intellectual property rights, which block competition from generic equivalents until such protections expire…
Read More